SEC Form 5 · accession 0000899243-17-004064
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Radovich
Officer — See Remarks
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 6:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 31, 2016 | A | 1,185 | $15.20 | A | 2,410 | D | |
| Common StockF2 | Jan 31, 2017 | A | 812 | $13.73 | A | 3,222 | D | |
| Common StockF1 | holding | — | — | — | 12,500 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were erroneously reported as being directly owned in the Reporting Person's original Form 4 filed by the Reporting Person. These shares are held by The Radovich Family Trust. The Reporting Person and his spouse are co-trustees of the trust and share voting and investment control.
- F2Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Remarks
Senior Vice President, Operations